Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

2020119 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT02484690.

Good health and well-being

Published in: JAMA Ophthalmology

Volume 138, Issue 9, pp. 955-955

Field-Weighted Citation Impact: 11.27